查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
T 细胞治疗市场，按治疗类型、适应症、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1364703

T 细胞治疗市场，按治疗类型、适应症、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

T-Cell Therapy Market, By Therapy Type, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年 T 细胞治疗市场规模为 27.086 亿美元，2023 年至 2030 年复合年增长率为 34.9%。

T细胞治疗市场-市场动态

对开发治疗疾病的新疗法的日益关注预计将推动 T 细胞治疗市场的成长。

随着全球疾病（特别是癌症）盛行率的上升，迫切需要更有效和量身定制的治疗方法。据美国国家癌症研究所称，到 2023 年，美国将有大约 200 万人被诊断出患有癌症。估计有 297,790 名女性和 2,800 名男性将被诊断出患有乳癌，这使其成为最常见的癌症诊断。 T 细胞治疗正在成为一种可行的治疗选择，特别是对于患有抗药性或復发性疾病的个体。鑑于 T 细胞治疗的潜力，人们在研究和开发方面投入了大量资金。此外，推动新型生物疗法的研究以及增加生物製剂的供应和安全性预计将为 T 细胞疗法市场提供成长机会。然而，严重危及生命的毒性、适度的抗肿瘤活性、抗原逃脱、运输受限和肿瘤浸润有限是限制市场成长的因素。

T 细胞治疗市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球 T 细胞治疗市场在预测期内（2023-2030 年）每年将以 34.9% 左右的复合年增长率成长
  • 由于癌症负担不断增加以及 T 细胞疗法的研发不断增加，T 细胞疗法产业预计将快速成长。
  • 根据治疗类型细分，预计 CAR T 细胞疗法将在 2022 年显示最大的市场份额
  • 根据适应症细分，血液系统恶性肿瘤是2022年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

T 细胞治疗市场-細項分析：

全球 T 细胞治疗市场根据治疗类型、适应症和区域进行细分。

根据治疗类型，市场分为三类： CAR T细胞疗法、基于细胞受体（TCR）的疗法和基于肿瘤浸润淋巴细胞（TIL）的疗法。 CAR T 细胞治疗领域预计将主导市场成长。 CAR-T 疗法是 T 细胞疗法的一种，其中 T 细胞经过基因工程改造，表达可特异性靶向癌细胞的受体 (CAR)。

根据适应症，市场分为两类：血液恶性肿瘤、实体肿瘤和其他。血液恶性肿瘤主导着市场成长。 CAR-T细胞免疫疗法被广泛认为是急性淋巴性白血病（ALL）、多发性骨髓瘤（MM）、慢性淋巴球白血病（CLL）、急性骨髓性白血病（AML）、何杰金氏淋巴瘤等血液系统恶性肿瘤患者的重要治疗选择。淋巴瘤（HL）和非何杰金氏淋巴瘤（NHL）。

T 细胞治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。由于越来越多的製药公司专注于开发过继疗法，预计北美将主导市场的成长，北美，特别是美国，拥有无数的生物技术新创公司、着名的研究机构和一些世界上最大的製药公司。这些组织积极投资并推动新型疗法的利润，例如过继性 T 细胞疗法。例如，Fate Therapeutics, Inc是一家临床阶段的生物製药公司，致力于为癌症患者开发程序化细胞免疫疗法，该公司展示了几种旨在实现现成的基于细胞的癌症免疫疗法的新策略的临床前资料在第 64 届美国血液学会 (ASH) 年会暨博览会上，无需进行预处理化疗。

製药业仍然是创新的温床，新治疗模式的发展、未满足的需求的严重性以及药物基因组学、数位疗法和人工智慧等技术的重要性日益增加，推动了製药业的活动。此外，由于与嵌合抗原受体（CAR）-T细胞疗法和T细胞受体（TCR）等T细胞疗法相关的产品批准不断增长，预计欧洲和亚太地区将推动T细胞疗法市场的显着增长-基于和基于肿瘤浸润淋巴细胞（TIL）。

T细胞治疗市场-竞争格局：

一些新的市场参与者正在推动 T 细胞治疗领域的创新。一些公司专注于下一代 CAR-T 疗法，而其他公司则正在研究替代细胞类型、更安全的设计或削减成本的策略。此外，新型CAR-T疗法的强劲发展也体现在企业积极利用智慧财产权以及大量的研发投入。製造商展示了CAR-T技术的专利和临床概况，涵盖目前的临床试验环境、尖端的CAR相关发明、主要参与者以及它们如何相互作用以产生新技术。此外，T 细胞治疗最初更集中于北美和欧洲部分地区等地区。亚太地区、拉丁美洲和中东的监管批准可以开闢大型新市场，随着企业扩大业务范围增加需求。

最近的发展：

2019 年10 月，领先的科技公司默克宣布收购了位于美国马萨诸塞州威尔布拉汉姆的FloDesign Sonics，该公司开发了一种独特的声学细胞处理平台，用于细胞和基因治疗製造的工业化。财务细节并未揭露。

目录

第一章：T 细胞治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按治疗类型分類的 T 细胞治疗市场片段
    • 按适应症分類的 T 细胞治疗市场片段
    • 按国家/地区分類的 T 细胞治疗市场片段
    • 按地区分類的 T 细胞治疗市场片段
  • 竞争洞察

第 3 章：T 细胞治疗主要市场趋势

  • T 细胞治疗市场驱动因素
    • 市场驱动因素的影响分析
  • T细胞治疗市场限制
    • 市场限制影响分析
  • T 细胞治疗市场机会
  • T细胞治疗市场未来趋势

第 4 章：T 细胞治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：T 细胞治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：T 细胞治疗市场格局

  • 2022 年 T 细胞治疗市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：T 细胞治疗市场 - 依治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • CAR T细胞疗法
    • 基于 T 细胞受体 (TCR)
    • 基于肿瘤浸润淋巴细胞 (TIL)

第 8 章：T 细胞治疗市场 - 依适应症分类

  • 概述
    • 按指标分類的细分市场占有率分析
    • 血液系统恶性肿瘤
    • 实体肿瘤
    • 其他的

第 9 章：T 细胞治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美 T 细胞疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模和预测（按指标）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲 T 细胞疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模与预测（按指标）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区 T 细胞疗法主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太地区市场规模与预测（依指标）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲 T 细胞疗法主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模与预测（按指标）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲 T 细胞疗法主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模和预测（按治疗类型）
    • 中东和非洲市场规模及预测（依指标）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - T 细胞治疗产业

  • 竞争仪表板
  • 公司简介
    • Novartis AG
    • Merck KGaA
    • Gilead Sciences Inc.
    • TCR2 Therapeutics Inc
    • Bluebird Bio Inc.
    • Sorrento Therapeutics
    • Fate Therapeutics
    • Pfizer Inc.
    • Amgen
    • Celgene Corporation

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1751

REPORT HIGHLIGHT

T-Cell Therapy Market size was valued at USD 2,708.6 Million in 2022, expanding at a CAGR of 34.9% from 2023 to 2030.

T-cell therapy is a form of immunotherapy in which T-cells, a type of white blood cell, are used to treat specific disorders, most notably cancer. There are two main types of T-cell transfer therapy tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy. T-cell transfer therapy was initially investigated for the treatment of metastatic melanoma since melanomas frequently cause a robust immune response and have a high number of TILs. TIL treatment has been shown to be successful in some cases of melanoma and has achieved encouraging results in other cancers such as cervical squamous cell carcinoma and cholangiocarcinoma. However, T-cell therapy is a key advancement in cancer treatment. Conversely, like many medicines, it comes with both enormous promise and significant challenges. There is continuing research to increase the efficacy, safety, and accessibility of these medicines.

T-Cell Therapy Market- Market Dynamics

The rising focus on Developing new therapies for the treatment of diseases is expected to drive the growth of the T-cell therapy market.

As the global prevalence of diseases, particularly cancer, rises, there is an urgent requirement for more effective and tailored therapies. According to the National Cancer Institute, in 2023, roughly 2.0 million people will be diagnosed with cancer in the United States. An estimated 297,790 women and 2,800 men will be diagnosed with breast cancer, which makes it the most common cancer diagnosis. T-cell treatments are emerging as a viable treatment option, particularly for individuals suffering from resistant or recurrent diseases. Given the potential of T-cell treatments, enormous investment has been made in research and development. Furthermore, advancing research on novel biotherapies and increasing the supply and safety of biologics are the factors that are expected to provide growth opportunities for the T-cell therapy market. However, severe life-threatening toxicities, modest anti-tumor activity, antigen escape, restricted trafficking, and limited tumor infiltration are the factors that restrict the growth of the market.

T-Cell Therapy Market- Key Insights

  • As per the analysis shared by our research analyst, the global T-Cell Therapy market is estimated to grow annually at a CAGR of around 34.9% over the forecast period (2023-2030)
  • The T-cell therapy industry is expected to grow at a rapid pace due to the rising cancer burden and increased research and development to create T-cell therapy.
  • Based on Therapy type segmentation, CAR T-cell Therapy was predicted to show maximum market share in the year 2022
  • Based on Indication segmentation, Hematologic Malignancies was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

T-Cell Therapy Market- Segmentation Analysis:

The Global T-Cell Therapy Market is segmented on the basis of Therapy Type, Indication, and Region.

The market is divided into three categories based on Therapy type: CAR T-cell Therapy, Cell Receptor (TCR)-based, and Tumor Infiltrating Lymphocytes (TIL)-based. CAR T-cell Therapy segment is expected to dominate the market growth. CAR-T therapy is a type of T-cell therapy in which T-cells are genetically engineered to express a receptor (the CAR) that can specifically target cancer cells.

The market is divided into two categories based on Indication: Hematologic Malignancies, Solid Tumors, and Others. Hematologic Malignancies dominate the market growth. CAR-T-cell immunotherapy is widely recognized as an important treatment option for patients suffering from hematological malignancies such as acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL).

T-Cell Therapy Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to the increasing number of pharmaceutical companies focusing on developing adoptive therapies, North America, particularly the United States, is host to a myriad of biotech startups, prestigious research institutions, and some of the world's largest pharmaceutical companies. These organizations actively invest in and push the margins of novel therapeutics, such as adoptive T-cell therapy. For example, Fate Therapeutics, Inc, a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, presented preclinical data of several novel strategies designed to enable the administration of off-the-shelf cell-based cancer immunotherapies without conditioning chemotherapy at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. Furthermore, Europe and Asia Pacific are expected to propel significant growth in T-cell therapy Market, due to the Growing Product Approvals Associated with T-cell therapies like Chimeric antigen receptor (CAR)-T cell therapy and T Cell Receptor (TCR)-based and Tumor Infiltrating Lymphocytes (TIL)-based.

T-Cell Therapy Market- Competitive Landscape:

Several new market players are driving innovation in the field of T-cell therapy. Some are concentrating on next-generation CAR-T therapy, while others are investigating alternate cell types, safer designs, or cost-cutting strategies. Also, the robust development of new CAR-T therapies is characterized by the active use of intellectual property rights by firms, as well as substantial R&D investments. Manufacturers exhibit CAR-T technologies' patent and clinical landscape, covering the current clinical trial environment, cutting-edge CAR-related inventions, the main actors, and how they interact with one another to generate new technologies. Furthermore, T-cell treatments were initially more focused in regions such as North America and parts of Europe. Regulatory approvals in Asia-Pacific, Latin America, and the Middle East can open up large new markets, raising demand as corporations expand their reach.

Recent Developments:

In October 2019, Merck, a leading science and technology company, nowadays announced it had acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL T-CELL THERAPY MARKET KEY PLAYERS

  • Novartis AG
  • Merck KGaA
  • Gilead Sciences Inc.
  • TCR2 Therapeutics Inc
  • Bluebird Bio Inc.
  • Sorrento Therapeutics
  • Fate Therapeutics
  • Pfizer Inc.
  • Amgen
  • Celgene Corporation

GLOBAL T-CELL THERAPY MARKET, BY THERAPY TYPE

  • CAR T-cell Therapy
  • T Cell Receptor (TCR)-based
  • Tumor Infiltrating Lymphocytes (TIL)-based

GLOBAL T-CELL THERAPY MARKET, BY INDICATION

  • Hematologic Malignancies
  • Solid Tumors
  • Others

GLOBAL T-CELL THERAPY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. T-Cell Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. T-Cell Therapy Market Snippet by Therapy Type
    • 2.1.2. T-Cell Therapy Market Snippet by Indication
    • 2.1.3. T-Cell Therapy Market Snippet by Country
    • 2.1.4. T-Cell Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. T-Cell Therapy Key Market Trends

  • 3.1. T-Cell Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. T-Cell Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. T-Cell Therapy Market Opportunities
  • 3.4. T-Cell Therapy Market Future Trends

4. T-Cell Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. T-Cell Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. T-Cell Therapy Market Landscape

  • 6.1. T-Cell Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. T-Cell Therapy Market - By Therapy Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
    • 7.1.2. CAR T-cell Therapy
    • 7.1.3. T Cell Receptor (TCR)-based
    • 7.1.4. Tumor Infiltrating Lymphocytes (TIL)-based

8. T-Cell Therapy Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 8.1.2. Hematologic Malignancies
    • 8.1.3. Solid Tumors
    • 8.1.4. Others

9. T-Cell Therapy Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. T-Cell Therapy Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. T-Cell Therapy Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. T-Cell Therapy Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. T-Cell Therapy Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. T-Cell Therapy Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- T-Cell Therapy Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Novartis AG
    • 10.2.2. Merck KGaA
    • 10.2.3. Gilead Sciences Inc.
    • 10.2.4. TCR2 Therapeutics Inc
    • 10.2.5. Bluebird Bio Inc.
    • 10.2.6. Sorrento Therapeutics
    • 10.2.7. Fate Therapeutics
    • 10.2.8. Pfizer Inc.
    • 10.2.9. Amgen
    • 10.2.10. Celgene Corporation

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE T-Cell Therapy Market: Therapy Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global T-Cell Therapy Market, by Therapy Type 2018-2030 (USD Million)
  • TABLE T-Cell Therapy Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global T-Cell Therapy Market, by Indication 2018-2030 (USD Million)
  • TABLE T-Cell Therapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global T-Cell Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE North America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Europe T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Latin America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)